First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1179-1934
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat ; volume:35 ; number:3 ; day:23 ; month:3 ; year:2021 ; pages:331-344 ; date:3.2021
CNS drugs ; 35, Heft 3 (23.3.2021), 331-344, 3.2021

Urheber
Antonijoan, Rosa María
Ferrero-Cafiero, Juan Manuel
Coimbra, Jimena
Puntes, Montse
Martínez-Colomer, Joan
Arévalo, María Isabel
Mascaró, Cristina
Molinero, Cesar
Buesa, Carlos
Maes, Tamara
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s40263-021-00797-x
URN
urn:nbn:de:101:1-2021051506143974839302
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:01 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Antonijoan, Rosa María
  • Ferrero-Cafiero, Juan Manuel
  • Coimbra, Jimena
  • Puntes, Montse
  • Martínez-Colomer, Joan
  • Arévalo, María Isabel
  • Mascaró, Cristina
  • Molinero, Cesar
  • Buesa, Carlos
  • Maes, Tamara
  • SpringerLink (Online service)

Ähnliche Objekte (12)

First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults

First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults

Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist

Human Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC42, a Novel Farnesoid X Receptor Agonist

Pharmacokinetics and Pharmacodynamics of Posaconazole

Pharmacokinetics and Pharmacodynamics of Posaconazole

Journal of pharmacokinetics and pharmacodynamics

Zeitschrift

Journal of pharmacokinetics and pharmacodynamics

Pharmacokinetics and Pharmacodynamics of Tedizolid

Pharmacokinetics and Pharmacodynamics of Tedizolid

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp

Pharmacokinetics and Pharmacodynamics of Ibrexafungerp

Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study

Safety, Tolerability, Pharmacokinetics and Initial Pharmacodynamics of a Subcommissural Organ-Spondin-Derived Peptide: A Randomized, Placebo-Controlled, Double-Blind, Single Ascending Dose First-in-Human Study

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants

Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib

Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib

Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide

Clinical Pharmacokinetics and Pharmacodynamics of Lenalidomide

Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine

Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine

Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin

Clinical Pharmacokinetics and Pharmacodynamics of Voclosporin

Verbundene Objekte